Suppr超能文献

[心肌梗死溶栓治疗——结局优化方法]

[Thrombolysis in myocardial infarction-outcome optimization methods].

作者信息

Kharash L M, Goldhammer E I, Abinader E I

出版信息

Klin Med (Mosk). 1998;76(9):25-9.

PMID:9821369
Abstract

Early reperfusion in acute myocardial infarction (AMI) has been shown to reduce the extent of myocardial necrosis and to improve short and long term prognosis. Gender, smoking, age and site of infarct location may be regarded as prognostic factors for the outcome of AMI and of thrombolytic therapy with streptokinase (STK). The aim of this study was to identify factors, which are related to the results of thrombolytic therapy by STK in AMI. 156 patients (122 males and 34 females) treated with STK were retrospectively analyzed: they were subdivided into 3 groups according to the presumed success of thrombolytic therapy based on the accepted clinical and angiographic TIMI flow criteria. Group 1 = successful (88 patients), group 2 = probably successful (20 patients) and group 3 = failed thrombolysis (48 patients). Multiple regression analysis showed that Killip class (p = 0.0005), time from pain onset to thrombolysis initiation (p = 0.02) and the time of the day in which thrombolysis began (p = 0.037) are independent major predictive factors for successful thrombolytic therapy by STK in AMI. Gender, age, smoking and some risk factors are not of similar predictive power. These results may guide us in the optimization of thrombolytic therapy by STK in AMI, different dose regimens for different times of day and probably preference for primary PTCA in the early morning hours.

摘要

急性心肌梗死(AMI)早期再灌注已被证明可减少心肌坏死范围并改善短期和长期预后。性别、吸烟、年龄和梗死部位可被视为AMI及链激酶(STK)溶栓治疗结果的预后因素。本研究的目的是确定与AMI患者STK溶栓治疗结果相关的因素。对156例接受STK治疗的患者(122例男性和34例女性)进行回顾性分析:根据基于公认的临床和血管造影TIMI血流标准推测的溶栓治疗成功率,将他们分为3组。第1组 = 成功(88例患者),第2组 = 可能成功(20例患者),第3组 = 溶栓失败(48例患者)。多元回归分析显示,Killip分级(p = 0.0005)、从疼痛发作到开始溶栓的时间(p = 0.02)以及开始溶栓的时间(p = 0.037)是AMI患者STK溶栓治疗成功的独立主要预测因素。性别、年龄、吸烟和一些危险因素没有类似的预测能力。这些结果可能会指导我们优化AMI患者STK溶栓治疗,根据一天中的不同时间采用不同的剂量方案,并可能在清晨时段优先选择直接经皮冠状动脉腔内血管成形术(PTCA)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验